Since heterologous rAd/rLCMV PB immunization significantly increased hgp100-specific CD8+ T cell frequencies, we sought to investigate whether they were proficient to protect mice from a B16.F10 melanoma challenge. The gene discussed is CD8A; the disease is melanoma.